Professor of Medicine
Christian Medical College, Vellore, India
Ranipet, Tamil Nadu, India
Alok Srivastava, MD, FRACP, FRCPA, FRCP
Christian Medical College, Vellore, India
Alok Srivastava is a Professor of Medicine in the Department of Haematology, and head of the Centre for Stem Cell Research at the Christian Medical College (CMC), Vellore in India. Dr. Srivastava has been involved with the management of patients with bleeding disorders for over 25 years with particular focus on management in resoiurce constrained environments. The recent focus of his group has also included assessment of novel therapies in different clinical trials with a major program for developing novel gene therapy for hemophilia. He leads the World Federation of Hemophilia designated International Hemophilia Training Center at CMC, Vellore. Dr. Srivastava is President of the Indian Association for Haemophilia & Allied Disorders. He is also the chair of the steering committee of the Association for Haemophilia & Allied Disorders – Asia-Pacific. He was the chair of the FVIII/IX subcommittee of the Scientific and Standardization Committee (SSC), International Society of Thrombosis and Haemostasis (ISTH) from 2006-2010. He was on the board of the WFH from 2002-2014 and served as the Vice-President (Medical) from 2012-2014. He has led the writing group for all three editions of the WFH guidelines for the management of hemophilia.
SSC 12.7 - Anti-AAV antibodies and their measurement - Towards standardization
Sunday, June 25, 2023
17:30 – 17:40 ET
OC 69.6 - Hemophilia - Novel Therapies II
Wednesday, June 28, 2023
10:15 – 11:30 ET